Abstract
The defining difference between genetic and traditional medicine is that genetic findings have implications not just for the patient, but also for their relatives. Discussion of a test result between parent and child is both a transformative and a translational moment in the life of a family. Parents report wanting help in talking to their children. The challenge for genetic counselors and other providers is to be able to recognize which issues are at the core of parental distress and be able to offer recommendations to empower and support parents. The complexity of potential genetic findings, including variants of uncertain significance (VUS) and incidental findings have vastly increased, requiring considerable explanation and leaving less time for discussion of emotional issues. While the nature of the testing (single gene to multigene panel and genomic testing) is dramatically changing, the nature of parent concerns remains remarkably constant. Families differ in many respects, so no “recipe” suffices to answer parents’ questions about how this important task should be approached in each family. Successful consultation to parents requires true counseling, matching parents’ fears and questions with information, exploration and advice specific to their concerns, their circumstances and strengths.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Academy of Pediatrics Committee on Bioethics, Committee on Genetics and, the American College of Medical Genetics and Genomics Social, Ethical and Legal Issues Committee, Ethical and Policy Issues in Genetic Testing and Screening of Children (2013). Pediatrics, 131, 620–622.
American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure (1998). Professional disclosure of familial genetic information. American Journal of Human Genetics, 62, 474–483.
Borzekowski, D. L. G., Guan, Y., Smith, K. C., Erby, L. H., & Roter, D. L. (2014). The Angelina effect: immediate reach, grasp and impact of going public. Genetics in Medicine, 16(7), 516–521.
Bowlby, J. (1980). Attachment and Loss: Vol. III Loss: Sadness and Depression, pp. 38–43. New York: Basic Books, Publishers.
Bradbury, A. R., Dignam, J. J., Ibe, C. N., Auh, S. L., Hlubocky, F. J., Cummings, S. A., White, M., Olopade, O. I., & Daugherty, C. K. (2007). How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. Journal of Clinical Oncology, 25(24), 3705–3711.
Bradbury, A. R., Patrick-Miller, L., Pawlowski, K., Ibe, C. N., Cummings, S. A., Hlubocky, F., Olopade, O. I., & Daugherty, C. K. (2009). Psychooncology, 18(2), 200–208. doi:10.1002/pon.1384.
Bradbury, A. R., Patrick-Miller, L., Egleston, B. L., Schwartz, L. A., Sands, C. B., Shorter, R., Moore, C. W., Tuchman, L., Rauch, P., Malhotra, S., Rowan, B., Van Decker, S., Schmidheiser, H., Bealin, L., Sicilia, P., & Daly, M. B. (2012). Knowledge and perceptions of familial and genetic risks for breast cancer risk in adolescent girls. Breast Cancer Research and Treatment, 136, 749–757.
Clark, S., Bluman, L. G., Borstelmann, N., Regan, K., Winer, E. P., Rimer, B. K., & Skinner, C. S. (2000). Patient motivation, satisfaction, and coping in genetic counseling and testing for BRCA1 and BRCA2. Journal of Genetic Counseling, 9(3), 219–235.
Costalas, J.W., Itzen, M., Malick, J., Babb, J.S., Bove, B., Godwin, A.K., Daly, M.B. (2003). Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program’s experience. American Journal of Medical Genetics Part C (Seminars in Medical Genetics) 119C, 11–18.
Dean, M. (2015). Celebrity health announcements and online health information seeking: an analysis of Angelina Jolie’s preventative health decision. Health Communication, 17, 1–10.
Denayer, L., Boogaerts, A., Philippe, K., Legius, E., & Evers-Kiebooms, G. (2009). BRCA1/2 predictive testing and gender: uptake, motivation and psychological characteristics. Genetic Counseling, 20(4), 293–305.
Dheensa, S., Fenwick, A., & Lucassen, A. (2016). Is this knowledge mine and nobody else’s? I don't feel that.’ patient views about consent, confidentiality and information-sharing in genetic medicine. Journal of Medical Ethics, 0, 1–6. doi:10.1136/medethics-2015-102781.
Evans, D. G., Wisely, J., Clancy, T., Lalloo, F., Wilson, M., Johnson, R., Duncan, J., Barr, L., Gandhi, A., & Howell, A. (2015). Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women. Breast Cancer Research, 17, 143. doi:10.1186/s13058-015-0650-8.
Fecteau, H., Vogel, K. J., Hanson, K., & Morille-Corneilius, S. (2014). The evolution of cancer risk assessment in the era of next generation sequencing. Journal of Genetic Counseling, 23, 33–42.
Himes, D. O., Clayton, M. F., Donaldson, G. W., Ellington, L., Buys, S. S., & Kinney, A. Y. (2016). Breast cancer risk perceptions among relatives of women with uninformative negative BRCA1/2 test results: the moderating effect of the amount of information shared. Journal of Genetic Counseling, e-publication ahead of print., 25, 258–269.
Kenen, R., Ardern-Jones, A., & Eeles, R. (2004). We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer (HBOC). Psycho-Oncology, 13, 335–345.
Klitzman, R. (2009). Am I my genes?”: questions of identity among individuals confronting genetic disease. Genetic. Medicine, 11(12), 880–889.
Malcolm, C. M., Javed, M. U., & Nguyen, D. (2015). Has the Angelina Jolie effect led to an increase in risk reducing mastectomy and breast reconstruction in Wales: a retrospective, single Centre cohort study. Journal of Plastic and Reconstructive Surgery, 27(3), 717–718.
Offit, K. (2011). Personalized medicine: new genomics, old lessons. Human Genetics, 130, 3–14. doi:10.1007/s00439-011-1028-3.
Patenaude, A. F., Dorval, M., DiGianni, L. S., Schneider, K. A., Chittenden, A., & Garber, J. E. (2006). Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Journal of Clinical Oncology, 24(4), 700–706.
Patenaude, A. F., DeMarco, T. A., Peshkin, B. N., Valdimarsdottir, H., Garber, J. E., Schneider, K. A., Hewitt, L., Hamilton, J., & Tercyak, K. P. (2013a). Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice. Journal of Genetic Counseling, 22(3), 303–314. doi:10.1007/s10897-012-9549-z.
Patenaude, A. F., Tung, N., Ryan, P. D., Ellisen, L. W., Hewitt, L., Schneider, K. A., Tercyak, K. P., Aldridge, J., & Garber, J. E. (2013b). Young adult daughters of BRCA1/2-positive mothers: what do they know about hereditary cancer and how much do they worry? Psychooncology, 22(9), 2024–2031. doi:10.1002/pon.3257.
Peshkin, B. N., DeMarco, T. A., & Tercyak, K. P. (2010). On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children. Familial Cancer, 9, 89–97.
Rainville, I. R., & Rana, H. (2014). Next-generation sequencing for inherited breast cancer risk: counseling through the complexity. Current Oncology Reports, 16, 371.
Sabogal, F., Marin, G., Otero-Sabogal, R., Marin, B., & Perez-Stable, E. (1987). Hispanic families and acculturation: what changes and what doesn’t? Hispanic Journal of Behavioral Science, 4, 397–412.
Samama, D., Hasson-Ohayon, I., Perry, S., Morag, O., & Goldzweig, G. (2014). Preliminary report of the relationship between experience of death of a relative, illness perception and psychological outcome among BRCA carriers. Psychology, Health and Medicine, 19(6), 698–704. doi:10.1080/13548506.2013.861600.
Tercyak, K. P., Hughes, C., Main, D., Snyder, C., Lynch, J. F., Lynch, H. T., & Lerman, C. (2001). Parental communication of BRCA1/2 genetic test results to children. Patient Education and Counseling, 42(3), 213–224.
Tercyak, K. P., Peshkin, B. N., DeMarco, T. A., Brogan, B. M., & Lerman, C. (2002). Parent-child factors and their effect on communicating BRCA1/2 test results to children. Patient Education and Counseling, 47(2), 145–153.
Tercyak, K. P., Peshkin, B. N., DeMarco, T. A., Patenaude, A. F., Schneider, K. A., Garber, J. E., Valdimarsdottir, H. B., & Schwartz, M. D. (2007). Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children. Genetic Testing, 11, 249–255.
Valverde, K. D. (2006). Why me? Why not me? Journal of Genetic Counseling, 15(6), 461–463. doi:10.1007/s10897-006-9055-2.
Weitzel, J. N., Blazer, K. R., MacDonald, D. J., Culver, J. O., & Offit, K. (2011). Genetics, genomics and cancer risk assessment. CA. A Cancer Journal for Clinicians, 61, 327–359.
Williams-Piehota, P., Pizarro, J., Schneider, T. R., Mowad, L., & Salovey, P. (2005). Matching health messages to monitor-blunter styles to motivate screening mammography. Health Psychology, 24(1), 58–67.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Requirements
This paper does not describe a research study and therefore IRB review was not required. Patient examples have been de-identified.
Funding
No funding.
Conflict of Interest
Authors Patenaude and Schneider declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Patenaude, A.F., Schneider, K.A. Issues Arising in Psychological Consultations to Help Parents Talk to Minor and Young Adult Children about their Cancer Genetic Test Result: a Guide to Providers. J Genet Counsel 26, 251–260 (2017). https://doi.org/10.1007/s10897-016-0010-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-016-0010-6